SAB-Y15

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSAB-Y15
Drug Alias NameSAB-Y15
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of Action78 kDa glucose-regulated protein modulators
Targets78 kDa glucose-regulated protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSyntab Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntab Therapeutics Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A